Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 28, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

What is the patent landscape for Rabeprazole Sodium, and what generic alternatives are available?

Rabeprazole Sodium is a drug marketed by Teva Pharms Usa, Dr Reddys Labs Ltd, Breckenridge Pharm, Aurobindo Pharma Ltd, Lupin Ltd, Torrent Pharms Ltd, Kremers Urban Pharms, Amneal Pharms, and Mylan Pharms Inc. and is included in nine NDAs.

The generic ingredient in RABEPRAZOLE SODIUM is rabeprazole sodium. There are twenty-nine drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the rabeprazole sodium profile page.

Summary for Tradename: RABEPRAZOLE SODIUM

Suppliers / Packagers: see list17
Bulk Api Vendors: see list52
Clinical Trials: see list958
Patent Applications: see list592
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:RABEPRAZOLE SODIUM at DailyMed

Pharmacology for Tradename: RABEPRAZOLE SODIUM

Drug ClassProton Pump Inhibitor
Mechanism of ActionProton Pump Inhibitors
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa
rabeprazole sodium
TABLET, DELAYED RELEASE;ORAL076822-001Nov 8, 2013ABRXNoNo► Subscribe► Subscribe
Kremers Urban Pharms
rabeprazole sodium
TABLET, DELAYED RELEASE;ORAL090678-001Nov 8, 2013ABRXNoNo► Subscribe► Subscribe
Aurobindo Pharma Ltd
rabeprazole sodium
TABLET, DELAYED RELEASE;ORAL205761-001Feb 17, 2017ABRXNoNo► Subscribe► Subscribe
Amneal Pharms
rabeprazole sodium
TABLET, DELAYED RELEASE;ORAL204179-001Jul 31, 2015ABRXNoNo► Subscribe► Subscribe
Dr Reddys Labs Ltd
rabeprazole sodium
TABLET, DELAYED RELEASE;ORAL076824-001Nov 8, 2013ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Identify first generic entrants
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus